229 related articles for article (PubMed ID: 33908148)
1. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group.
Bueno F; Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Martín Calvo C; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Duarte R; Piñana JL; Navarro D;
Transpl Infect Dis; 2021 Aug; 23(4):e13627. PubMed ID: 33908148
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus DNA load monitoring in stool specimens for anticipating the occurrence of intestinal acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Is it of any value?
Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Gómez MD; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
Transpl Infect Dis; 2020 Dec; 22(6):e13440. PubMed ID: 32772456
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting.
Forqué L; Albert E; Piñana JL; Pérez A; Hernani R; Solano C; Navarro D; Giménez E
J Med Virol; 2023 Sep; 95(9):e29107. PubMed ID: 37721473
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Calvo CM; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Piñana JL; Navarro D;
Bone Marrow Transplant; 2021 Jun; 56(6):1281-1290. PubMed ID: 33319853
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group.
Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Calvo CM; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Bautista G; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Piñana JL; Navarro D
Am J Transplant; 2021 Jan; 21(1):258-271. PubMed ID: 32812351
[TBL] [Abstract][Full Text] [Related]
8. Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.
Huntley D; Giménez E; Pascual MJ; Hernández-Boluda JC; Gago B; Vázquez L; Piñana JL; García M; Pérez A; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Transpl Infect Dis; 2020 Feb; 22(1):e13206. PubMed ID: 31677215
[TBL] [Abstract][Full Text] [Related]
9. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
Cantoni N; Hirsch HH; Khanna N; Gerull S; Buser A; Bucher C; Halter J; Heim D; Tichelli A; Gratwohl A; Stern M
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1309-14. PubMed ID: 20353832
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
12. Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Guglieri-Lopez B; Perez-Pitarch A; Garcia-Cadenas I; Gimenez E; Barba P; Rabella N; Hernandez-Boluda JC; Fox L; Valcarcel D; Esquirol A; Ferriols-Lisart R; Sierra J; Solano C; Navarro D; Martino R; Piñana JL
Biol Blood Marrow Transplant; 2019 May; 25(5):1022-1030. PubMed ID: 30639821
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
Chen Y; Xu LP; Liu KY; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Han W; Wang JZ; Yan CH; Huang XJ
J Clin Virol; 2016 Feb; 75():10-5. PubMed ID: 26735213
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group.
Kimura SI; Tamaki M; Okinaka K; Seo S; Uchida N; Igarashi A; Ozawa Y; Ikegame K; Eto T; Tanaka M; Shiratori S; Nakamae H; Sawa M; Kawakita T; Onizuka M; Fukuda T; Atsuta Y; Kanda Y; Nakasone H
Ann Hematol; 2021 Dec; 100(12):3029-3038. PubMed ID: 34490500
[TBL] [Abstract][Full Text] [Related]
15. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.
Delia M; Carluccio P; Mestice A; Chiusolo P; Metafuni E; Bellesi S; Arpinati M; Milone GA; Martino M; Mazza P; Ingrosso C; Vacca A; Saporiti G; Zallio F; Attolico I; Pastore D; Specchia G; Albano F; Musto P
Transplant Cell Ther; 2021 Nov; 27(11):918.e1-918.e9. PubMed ID: 34403789
[TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
18. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]